Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFEST-RCT: Statins in Frail Elderly with Stroke/TIA
NCT06785727Phase 4Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2028
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of ulinastatin in ischemic stroke, Transient Ischemic Attack (TIA). Planned start Feb 2025; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT06785727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06785727.